End-stage renal disease,Hemodialysis
Conditions
Interventions
A study cohort on the effectiveness of clinical application of a hyperkalemia management model in maintenance hemodialysis patients:NA
Sponsors
China-Japan Friendship Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria for the retrospective study population: patients undergoing maintenance hemodialysis treatment at our dialysis center from January 2022 to June 2023; any gender, age =18 years. Inclusion criteria for prospective study: ? Inclusion criteria: patients with end-stage renal disease who are registered for maintenance hemodialysis treatment in our dialysis center; gender is not limited, age =18 years old; understand the purpose of the study agree to join and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1: Excluding patients who are on hemodialysis for acute renal failure and those who are on hemodialysis temporarily (<1 month in our center) for various reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical events associated with hyperkalemia;Serum potassium indicators; | — |
Countries
China
Contacts
Public ContactLiu YANG
China-Japan Friendship Hospital
Outcome results
None listed